<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440880</url>
  </required_header>
  <id_info>
    <org_study_id>Qasr Elainy</org_study_id>
    <nct_id>NCT02440880</nct_id>
  </id_info>
  <brief_title>Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section</brief_title>
  <official_title>Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays Cesarean sections became the most popular surgery worldwide with the consumption of
      the hospital resources and the continuous need to decrease the costs, work load and medical
      stuff engagement. One of the most common problem is the need to control pain post
      operatively, this issue increase the work load over the pain management team and increase
      lead to patient in satisfaction.

      This study will test the usage of dexamethasone with different doses (4 and 8 mg) either
      locally or intravenously (I.V.) with the local anesthetics in TAP (transversus abdominis
      plane) block to prolong the duration of the block and decrease the need of post-operative
      analgesics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nowadays Cesarean sections became the most popular surgery worldwide with the consumption of
      the hospital resources and the continuous need to decrease the costs, work load and medical
      stuff engagement. One of the most common problem is the need to control pain post
      operatively, this issue increase the work load over the pain management team and increase
      lead to patient in satisfaction.(1,2,3) The presence of the adjuvant which can be added to
      the conventional anesthetic medications can prolong the duration of action and decrease the
      need for frequent post-operative analgesics.(4,5) The idea of adding a catheter or placing an
      epidural catheter still have a quite limitation regarding the patients compliance, delayed
      ambulation and high costs, these limitations redirect the anesthetist again to the use of
      adjuvant with a single shot block to prolong the duration of it and decrease the need of
      subsequent analgesics.(6) Dexamethasone proved to be an effective adjuvant in prolongation of
      the nerve blocks with the question regarding the proper route and dose (7,8,9,10).

      This study will test the usage of dexamethasone with different doses (4 and 8 mg) either
      locally or intravenously (I.V.) with the local anesthetics in TAP (transversus abdominis
      plane) block to prolong the duration of the block and decrease the need of post-operative
      analgesics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>level of pain according to verbal analogue scale</measure>
    <time_frame>THREE DAYS</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>CONTROL</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TAP block without Dexamethasone neither intravenous nor in combination with the block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (TD8IS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone in combination with TAP block in dose of 8 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3(TD4IS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone in addition to TAP block in dose of 4 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4 (TSID8):</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone intravenous in addition to TAP block in dose of 8 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group5(TSID4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone intravenous 4mg+ TAP block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone in addition to TAP block in dose of 4 mg</intervention_name>
    <description>Dexamethasone in addition to TAP block in dose of 4 mg</description>
    <arm_group_label>Group 3(TD4IS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone in combination with TAP block in dose of 8 mg</intervention_name>
    <description>Dexamethasone in combination with TAP block in dose of 8 mg</description>
    <arm_group_label>Group 2 (TD8IS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone intravenous 4mg+ TAP block</intervention_name>
    <description>Dexamethasone intravenous in addition to TAP block in dose of 4 mg</description>
    <arm_group_label>Group5(TSID4)</arm_group_label>
    <other_name>Dexamethasone intravenous 4mg + TAP block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone intravenous in addition to TAP block in dose of 8 mg</intervention_name>
    <description>Dexamethasone intravenous + TAP block in dose of 8 mg</description>
    <arm_group_label>Group 4 (TSID8):</arm_group_label>
    <other_name>Dexamethasone intravenous 8mg+ TAP block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>TAP block without Dexamethasone neither intravenous nor in combination with the block</description>
    <arm_group_label>CONTROL</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient ASA (american society of anesthesia) I or II,

          -  aged between 18 and 45 scheduled for elective cesarean section.

        Exclusion Criteria:

          -  patient refusal,

          -  age below 18 or above 45 years,

          -  coagulopathy with INR (international normalized ratio) more than 1.5 or platelets
             below 100000,

          -  uncontrolled diabetes, uncontrolled hypertensive, addict patient,

          -  psychological instability, and

          -  allergy to the used drugs,

          -  failure of spinal,

          -  conversion to general of anesthesia,

          -  failure of application of TAP block.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Ali, LECTURER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesia department, faculty of medicine ,Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hassan Ali</last_name>
    <phone>+201001733687</phone>
    <email>hassan364@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Giza</state>
        <zip>1234</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HASSAN M ALI, LECTURER</last_name>
      <phone>+201001733687</phone>
      <email>hassan364@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Hassan Mohamed Ali</investigator_full_name>
    <investigator_title>lecturer in anesthesia department Cairo university</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

